Answers are grounded in this paper and cite their sources.
Ochrobactrum anthropi infection in newborn patients is rare, and the treatment is challenging because of its widespread and unpredictable resistance to antimicrobial agents and discrepancies between in vitro susceptibility and in vivo efficacy. We report the clinical and microbiological characteristics of Ochrobactrum anthropi bacteremia in a preterm patient.
No takes yet. Share an insight, caveat, or question.
Menezes et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: